DFX Corp Acquires MycoWorks to Consolidate Mycelium Materials Sector
February 3, 2024
MycoWorks, a producer of fungal-based “Fine Mycelium” materials (including its Reishi product), was acquired by DFX Corp in a strategic restructuring. The deal is intended to accelerate the commercialisation of MycoWorks’ Fine Mycelium technology platform after the company closed its South Carolina facility in November.
- Buyers
- DFX Corp
- Targets
- MycoWorks
- Industry
- Consumer Products
- Location
- United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
NewLeaf Brands Acquires Colorado-Based Mydecine Group
April 6, 2020
Biotechnology
NewLeaf Brands Inc. signed an LOI and subsequently a definitive agreement in April 2020 to acquire Mydecine Group, a Colorado-headquartered company focused on medicinal and infused mushroom cultivation, processing, product development and R&D. The deal contemplated the purchase of 100% of Mydecine for USD $850,000 payable in NewLeaf common shares; NewLeaf later operated the business as a wholly-owned subsidiary and rebranded to Mydecine Innovations Group.
-
Tekni-Plex Acquires Assets and Technologies of Fibro Corporation
January 19, 2022
Manufacturing
Tekni-Plex has acquired the assets and licensed technologies of Fibro Corporation, a Tacoma, Washington-based molded-fiber packaging developer, and folded the resources into its Dolco Packaging business. The acquisition expands Tekni-Plex's pulp-based and sustainable packaging capabilities for fresh food applications, enabling broader product offerings beyond egg cartons and meat trays.
-
Forest Road Acquisition Corp. Stockholders Approve Business Combination With Beachbody and Myx Fitness
June 24, 2021
Healthcare Services
Forest Road Acquisition Corp. (a SPAC) announced that its stockholders approved a proposed three-way business combination with The Beachbody Company Group and Myx Fitness Holdings. The transaction is expected to close on June 25, 2021 and will create a public company named The Beachbody Company, Inc., with shares and warrants trading on the NYSE under the ticker symbols “BODY” and “BODY WS,” respectively.
-
Millstone Medical Outsourcing Acquires MycoScience
November 14, 2022
Healthcare Services
Millstone Medical Outsourcing, an Arlington Capital Partners portfolio company, has completed the acquisition of MycoScience, a Willington, Connecticut-based provider of medical device and pharmaceutical laboratory and environmental testing services. The acquisition adds advanced laboratory and regulatory testing capabilities to Millstone's post-manufacturing and aftermarket services, enabling more in-house testing, faster time to market, and expanded end-to-end offerings.
-
Canopy Growth Acquires This Works
May 22, 2019
Consumer Products
Canopy Growth Corp. acquired London-based beauty and wellness brand This Works for £43 million. The deal gives Canopy a consumer-facing platform to expand into CBD-infused wellness and sleep products and extend its reach across This Works' existing international retail and e-commerce channels.
-
Ginkgo Bioworks to Acquire Zymergen
July 25, 2022
Biotechnology
Ginkgo Bioworks (NYSE: DNA) has entered into a definitive agreement to acquire Zymergen (Nasdaq: ZY) in an all-stock transaction valued at approximately $300 million market capitalization. The deal is expected to close in the first quarter of 2023, pending Zymergen stockholder approval, regulatory approvals, and other customary closing conditions.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.